The House of Reps is expected to pass a $6.3 billion piece of legislation designed to spur medical innovation, speed access to new drugs, expand mental health treatment, and combat opioid abuse.
Following the failure of the late-stage anti-cholesterol drug bococizumab, Pfizer cancelled plans to spend nearly $500 million to expand its Ireland manufacturing site.
A severe strain of H5N8 bird flu that has hit several countries in Europe leading to the culling of thousands of poultry was detected in wild ducks in Northern France, the farm ministry said.
Danish drugmaker Novo Nordisk A/S pulled advertising from Breitbart, the online news site formerly helmed by Stephen Bannon, special adviser to President-elect Donald Trump.
Does the U.S. Food and Drug Administration bear some culpability in the most recent deaths associated with Juno Therapeutics’ CART-T trial? Some industry observers and analysts seem to think so.
Israel’s Teva Pharmaceutical Industries has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
A sixth person has died in the Australian city of Melbourne after a storm triggered thousands of pollen allergy asthma attacks, the Victorian state government said.
France’s Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent for the time being.
Modern pharmacies have lost the personal touch that ma and pa shops once had as they grapple with a growing patient volume. Pharmaceutical executives would be wise to abandon their struggling system and adopt an entrepreneurial mindset.
At North Carolina Children’s Hospital, immune-compromised kids can experience the natural environment while getting around hospital rules – digging in dirt, poking into pitcher plants and observing other wonders of nature otherwise prohibited – thanks to a new device called the WonderSphere.